Drawing for BIOM'UP

USPTO serial 79232166

BIOM'UP

Reviewed by CopyMark Law Group

Reg. 5784099Status 709
Filing date
Status date
Registration date
Jun 25, 2019
Examiner
STOIDES, KATHERINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOM'UP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Bleaching preparations and cleaning substances for laundry use; cleaning, polishing and abrasive preparations, degreasing preparations for household purposes; non-medicated soaps; perfumery; essential oils; cosmetics; hair lotions; dentifrices; chemicals sold as components of cosmeticsSECTION 71 - CANCELLED—
005Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; hemostatic products, namely, medical diagnostic apparatus for coagulation factor assay testing and routine coagulation testing; sanitary preparations for medical purposes; chemical preparations for pharmaceutical or medical purposes, namely, for surgery, wound healing, hemostasis; medical and surgical dressings; plasters for surgical or medical use; surgical implants comprising biological tissues; membranes in the nature of implants comprising biological tissues made of collagen, absorbable polymers and natural biomaterials for medical, surgical and pharmaceutical use; wound dressings made of fabric or textiles for medical and surgical use to promote the regeneration of biological tissues and bones of the human body; medical and surgical dressings featuring collagen-based preparations, absorbable polymers or biomaterials with pharmaceutical effects for external and internal applications; surgical implants comprised of biomaterials made of collagen, absorbable polymers and natural biomaterials for promoting recovery and repairing bones and biological tissues; Pharmaceutical preparations, namely, blood-clotting preparations, including the form of powders, liquids and pastes; biological preparations for medical purposes for use in blood-clotting during surgery; biological tissues cultures for medical purposes; stem cells for medical useSECTION 71 - CANCELLED—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, artificial limbs, eyes and teeth; orthopedic braces; suture material; surgical and medical devices, namely, artificial biomaterials for augmentation of bone and tissue; prosthetic limbs, prosthetic ligaments and synthetic prosthesis tissues for general surgery, orthopedic surgery, cardio-thoracic surgery, maxillofacial surgery; surgical implants comprising artificial materials; bone substitutes; hemostatic products; medical fluid injectors, and aerosol, liquid and/or powdered sprays for administering sanitary preparations and sterilizing preparations for medical and surgical use; containers for applying, mixing, and storing solutions used for the treatment of hemorrhage and bleeding, namely, rigid and semi-rigid containers for solutions in solid or liquid form for medical use; Medical diagnostic apparatus for testing DNA and RNA samples, blood sugar levels, cancer cells, body tissue; surgical instruments for implanting prosthetic tissues in the human body; devices for regenerating biological tissues and bones of the human body; all these goods being for medical or surgical use; blood testing apparatus; orthopedic joint implants made of artificial materials; orthopedic support bandagesSECTION 71 - CANCELLED—
042Engineering services in the nature of evaluations, assessment and research in the fields of science and technology; research and development of new products for others; technical project studies, namely, scientific research and studies in the fields of biomaterials, surgery and medical devices; industrial analysis and research services in the field of biomaterials, surgery and medical devices; chemical analysis; testing of materials; scientific laboratory services; all these services being provided in connection with implantable surgical, medical, dental and veterinary devicesSECTION 71 - CANCELLED—
044Medical, veterinary and pharmaceutical compounding services; hygienic and beauty care for human beings or animals; Health care services; hospital services; medical assistance; plastic surgery; nursing homes; medical equipment rental; cognitive therapy servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 9, 2026C71TCANCELLED SECTION 71—
Jun 25, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 29, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 18, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 30, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 30, 2019FIMPFINAL DISPOSITION PROCESSED—
Sep 25, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 25, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 2, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 22, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 22, 2019ALIEASSIGNED TO LIE—
Feb 22, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 22, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 22, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 5, 2019LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 14, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 16, 2018LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jun 30, 2018RFNTREFUSAL PROCESSED BY IB—
Jun 13, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 13, 2018RFRRREFUSAL PROCESSED BY MPU—
Jun 5, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 4, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 25, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 21, 2018DOCKASSIGNED TO EXAMINER—
May 21, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 17, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance